Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-14 Sale | 2024-11-18 5:45 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 5,000 | $5.1726 | $25,863 | 44,857 (Direct) | View |
2023-08-10 Sale | 2023-08-11 4:36 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 6,500 | $6.0537 | $39,349 | 29,328 (Direct) | View |
2022-06-13 Sale | 2022-06-14 8:37 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 2,700 | $9.4789 | $25,593 | 6,515 (Direct) | View |
2021-09-09 Sale | 2021-09-13 4:40 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 19,109 | $16.74 | $319,976 | 31,091 (Direct) | View |
2021-06-15 Sale | 2021-06-17 5:01 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 5,000 | $19.42 | $97,122 | 15,200 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-17 Option Award | 2024-05-21 4:53 pm | N/A 2034-05-16 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 58,107 | $0 | 87,435 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:19 pm | N/A 2033-06-07 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 51,267 | $0 | 69,788 (Direct) | View |
2022-06-16 Option Award | 2022-06-21 4:55 pm | N/A 2032-06-15 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 36,713 | $0 | 43,228 (Direct) | View |
2021-09-09 Exercise | 2021-09-13 4:40 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 13,124 | $12.7 | 31,091 (Direct) | View |
2021-09-09 Exercise | 2021-09-13 4:40 pm | N/A 2030-06-10 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 19,109 | $0 | 31,091 (Direct) | View |
2021-09-09 Exercise | 2021-09-13 4:40 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 5,985 | $10.57 | 31,091 (Direct) | View |
2021-06-15 Exercise | 2021-06-17 5:01 pm | N/A 2030-06-10 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 4,015 | $0 | 15,200 (Direct) | View |
2021-06-15 Exercise | 2021-06-17 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 4,015 | $10.57 | 15,200 (Direct) | View |
2021-06-10 Option Award | 2021-06-14 4:36 pm | N/A 2031-06-09 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 15,000 | $0 | 20,200 (Direct) | View |
2020-06-11 Option Award | 2020-06-15 7:11 pm | N/A 2030-06-10 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 15,000 | $0 | 15,200 (Direct) | View |
2020-02-14 Option Award | 2020-02-19 4:20 pm | N/A 2030-02-13 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2020-02-19 4:19 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 0 | $0 | 200 (Direct) | View |